Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis

Annals of the Rheumatic Diseases

Volumn 67, Issue 7, 2008, Pages 991-997

  Statkute, L ^a   Oyama, Y ^a   Barr, W G ^a   Sufit, R ^a   Ho, S ^a   Verda, L ^a   Loh, Y ^a   Yaung, K ^a   Quigley, K ^a   Burt, R K ^a,b  

^a NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA B51 ANTIGEN; IMMUNOGLOBULIN; INFLIXIMAB; LEVAMISOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BEHCET DISEASE; CASE REPORT; CHEMOTHERAPY; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PERIPHERAL BLOOD STEM CELL; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SJOEGREN SYNDROME; STEM CELL MOBILIZATION; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADULT; BIOLOGICAL MARKERS; BLOOD COMPONENT TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VASCULITIS;

EID: 46849109758     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.070227     Document Type: Article

References (42)

1. Hoffman GS, Kerr GS, Leavit RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
2. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, et al. Relapses in patients with a systemic vasculitis. Q J Med 1993;86:779-89.
3. Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticods and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999;42:2666-73.
4. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
5. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371-80.
6. Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA, et al. Damage occurs early in systemic vasculitis and is an index of outcome. Q J Med 1997;90:391-9.
7. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 1998;37:57-63.
8. Pipitone N, Salvarani C. Systemic vasculitis: state of the art and emerging concepts. Curr Opin Rheumatol 2006;18:1-2.
9. Matteson EL, Gold KN, Block DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med 1996;101:129-34.
10. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988;27:258-64.
11. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006;54:3750- 60.
12. Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis 2006;65:508-14.
13. Daikeler T, Erley C, Mohren M, Amberger C, Einsele H, Kanz L, Kotter I. Fever and increasing cANCA titer after kidney and autologous stem cell transplantation for Wegener's granulomatosis. Ann Rheum Dis 2006;64:646-7.
14. Kotter I, Daikeler T, Amberger C, Tyndall A, Kanz L. Autologous stem cell transplantation of treatment-resistant systemic vasculitis - a single center experience and review of the literature. Clin Nephrol 64:485-9.
15. Hensel M, Breitbart A, Ho AD. Autologous hematopoietic stem-cell transplantation for Behcet's disease with pulmonary involvement. N Engl J Med 2001;344:69.
16. Maurer B, Hensel M, Max R, Fiehn C, Ho AD, Lorenz HM. Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis 2006;65:127-9.
17. Rossi G, Moretta A, Locatelli F. Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet's disease. Blood 2004;103:748-50.
18. Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behcet disease. International J Hematol 2003;77:82-5.
19. Tomonari A, Tojo A, Takahashi T, Iseki T, Ooi J, Takahashi S, et al. Resolution of Behcet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol 2004;83:464-6.
20. Rosler W, Manger B, Repp R, Kalden JR, Gramatzki M. Autologous PBPCT in a patient with lymphoma and Sjögren's syndrome: complete remission of lymphoma without control of the autoimmune disease. Bone Marrow Transplant 1998;22:211-13.
21. Ferraccioli G, Damato R, De Vita S, Fanin R, Damiani D, Baccarani M, Haematopoietic stem cell transplantation (HSCT) in a patient with Sjögren's syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease. Ann Rheum Dis 2001;60:174-6.
22. Minowa R, Miyagawa S, Fukumoto T, Majima T, Shimoyama T, Fujimura Y, Shirai T. Primary Sjögren's syndrome followed by chronic myelogenous leukemia: a case report with a ten year history. J Dermatol 1998;25:460-4.
23. Daikeler T, Kotter I, Tyndall CB, Attarbaschi A, Apperley J, Guardiola P, et al. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis - a retrospective analysis of patients recorded to the European Bone Marrow Transplantation (EBMT) and European League Against Rheumatism (EULAR) databases and a review of the literature. Ann Rheum Dis 2007;66:202-7.
24. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
25. Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423-46.
26. Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997;90:401-9.
27. Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L. Efficacy of the anti-TNF-alfa antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology 2002;41:1126-32.
28. De Groot K, Rasmussen N, Bacon PA, Tervaert JWC, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:2461-9.
29. Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, et al. A randomized, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for hematopoietic stem cell mobilization in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998;22:1035-41.
30. Burt RK, Fassas A, Snowden JA, Van Laar JM, Kozak T, Wulffraat NM, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001;28:1-12.
31. Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000;54:2147-50.
32. Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T, et al. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2007;39:317-29.
33. Vial T, Descotes J. Immune-mediated side effects of cytokines in humans. Toxicology 1995;105:31-57.
34. Parkkali T, Volin L, Siren MK, Ruutu T. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 1996;17:433-4.
35. Yokose N, Ogata K, Tamura H, An E, Nakamura K, Kamikubo K, et al. Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. Br J Cancer 1998;77:2286.
36. Katoh M, Takada M, Nakayama M, Umeda M. Pulmonary toxicity during granulocyte colony stimulating factor administration and neutrophils. Chest 1996;110:576-7.
37. Canales MA, Arrieta R, Gomez-Rioja R, Diez J, Jimenez-Yuste V, Hernandez-Navarro F. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors. J Hematother Stem Cell Res 2004;11:675-81.
38. Euler HH, Schwab UM, Schroeder JO. Filgrastim for lupus neutropenia. Lancet 1994;344:1513-14.
39. Verda L, Luo K, Kim DA, Bronesky D, Kohm AP, Miller SD, Statkute L, Oyama Y, Burt RK. Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis. Bone Marrow Transplant 2006;38:453-60.
40. Luqmani RA. Assessing disease activity in the systemic vasculitides. Curr Opin Rheumatol 2002;14:23-8.
41. Gaskin G, Savage COS, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991;6:689-94.
42. Boomsma MM, Stegeman CA, Van Der Leij MJ, Oost W, Hermans J, Kallenberg CG, et al. Prediction of relapses in Wegener's granulomatosis by measurement of anti-neutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43:2025-33.